Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

lopinavir, ritonavir, ketoconazole loaded solid lipid nanoparticles

Based on

1 Articles
2010 Most recent source

Composition

1

solid lipid nanoparticles

SLN
Type Nano Material
Formula
Role carriers
2

[1S-[1R*,(R*),3R*,4R*]]-N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenyl-methyl)pentyl]tetrahydro-a-(1-methyl-ethyl)-2-oxo-1-(2H)-pyrimidineacetamide

lopinavir LPV
Type Single Compound
Formula C37H48N4O5
Role loaded material
3

(5S,8S,10S,11S)-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid 5-thiazolyl-methyl ester

ritonavir RTV
Type Single Compound
Formula C37H48N6O5S2
Role loaded material
4

1-acetyl-4-[4-[[(2RS,4SR)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine

ketoconazole KCZ KTZ
Type Single Compound
Formula C26H28Cl2N4O4
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release dependent on drugs

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • lecithin
  • 1-stearoyl-rac-glycerol
  1. RAilxEm2w993HK6yGbuUl
Product

lopinavir, ritonavir, ketoconazole loaded solid lipid nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial